Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Vora

Showing results (281-290 of 294) with videos related to

Pageof 30
Sort By:
Nature Communications|September 14, 2019
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoproteinAimin Tang, Zhifeng Chen, Kara S Cox, et al.
Indian Journal of Cancer|August 9, 2014
Guidelines for treatment of recurrent or metastatic head and neck cancerP Parikh, V Patil, J P Agarwal, et al.
The New England Journal of Medicine|September 17, 2025
Clesrovimab for Prevention of RSV Disease in Healthy InfantsHeather J Zar, Eric A F Simões, Shabir A Madhi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 17, 2021
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocolJ Stutterheim, P de Lorenzo, I M van der Sluis, et al.
NPJ Vaccines|March 5, 2020
Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infectionAmy S Espeseth, Pedro J Cejas, Michael P Citron, et al.
Ebiomedicine|November 14, 2021
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxisBrian M Maas, Jos Lommerse, Nele Plock, et al.
Leukemia|October 30, 2013
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcomeC J Harrison, A V Moorman, C Schwab, et al.
Leukemia|July 24, 2015
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative studyJ M Boer, A van der Veer, D Rizopoulos, et al.
Journal of Neurointerventional Surgery|February 9, 2021
Endovascular thrombectomy time metrics in the era of COVID-19: observations from the Society of Vascular and Interventional Neurology Multicenter CollaborationAlexandra L Czap, Alicia M Zha, Jacob Sebaugh, et al.
Neurology|September 26, 2012
Vascular neurologists and neurointerventionalists on endovascular stroke care: polling resultsThanh N Nguyen, Osama O Zaidat, Randall C Edgell, et al.
Pageof 30

Showing results (281-290 of 294) with videos related to

Sort By:
Pageof 30
Nature Communications|September 14, 2019
A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoproteinAimin Tang, Zhifeng Chen, Kara S Cox, et al.
Indian Journal of Cancer|August 9, 2014
Guidelines for treatment of recurrent or metastatic head and neck cancerP Parikh, V Patil, J P Agarwal, et al.
The New England Journal of Medicine|September 17, 2025
Clesrovimab for Prevention of RSV Disease in Healthy InfantsHeather J Zar, Eric A F Simões, Shabir A Madhi, et al.
European Journal of Cancer (Oxford, England : 1990)|November 17, 2021
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocolJ Stutterheim, P de Lorenzo, I M van der Sluis, et al.
NPJ Vaccines|March 5, 2020
Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infectionAmy S Espeseth, Pedro J Cejas, Michael P Citron, et al.
Ebiomedicine|November 14, 2021
Forward and reverse translational approaches to predict efficacy of neutralizing respiratory syncytial virus (RSV) antibody prophylaxisBrian M Maas, Jos Lommerse, Nele Plock, et al.
Leukemia|October 30, 2013
An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcomeC J Harrison, A V Moorman, C Schwab, et al.
Leukemia|July 24, 2015
Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative studyJ M Boer, A van der Veer, D Rizopoulos, et al.
Journal of Neurointerventional Surgery|February 9, 2021
Endovascular thrombectomy time metrics in the era of COVID-19: observations from the Society of Vascular and Interventional Neurology Multicenter CollaborationAlexandra L Czap, Alicia M Zha, Jacob Sebaugh, et al.
Neurology|September 26, 2012
Vascular neurologists and neurointerventionalists on endovascular stroke care: polling resultsThanh N Nguyen, Osama O Zaidat, Randall C Edgell, et al.
Pageof 30